Screener
Nektar Therapeutics NKTR Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $149,578 | $15,116 |
| Short-term investments | 419,026 | 230,636 |
| Other current assets (including $432 and $429 as of March 31, 2026 and December 31, 2025, respectively, from a related party) | 20,437 | 20,514 |
| Total current assets | 589,041 | 266,266 |
| Long-term investments | 162,993 | — |
| Other assets | 11,237 | 14,140 |
| Total assets | $763,271 | $280,406 |
Item 1. Condensed Consolidated Financial Statements—Unaudited:
FAQ
- What is Nektar Therapeutics's prepaid & other current?
- Nektar Therapeutics (NKTR) reported prepaid & other current of $20.44M in Q1 2026.
- How has Nektar Therapeutics's prepaid & other current changed year-over-year?
- Nektar Therapeutics's prepaid & other current increased by 81.2% year-over-year, from $11.28M to $20.44M.
- What is the long-term trend for Nektar Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Nektar Therapeutics's prepaid & other current has grown at a -1.3% compound annual growth rate (CAGR), from $21.93M to $20.51M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Nektar Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude